500
Participants
Start Date
November 27, 2017
Primary Completion Date
December 31, 2017
Study Completion Date
December 31, 2017
Original consent form
Participants will review the full-length, original consent form for the clinical trial.
Shortened consent form
Participants will review a shortened consent form for the clinical trial, which includes only material indicated as important by 2/3 of participants from a previous study.
Reordered, shortened consent form
Participants will review a reordered, shortened consent form. This form is based on the shortened consent form, but the sections are reordered based on a previous study, such that sentences previously rated as more likely to impact a participant's decision is more likely to be presented first (except for an initial introductory section).
Shortened consent form with a highlights box
Participants will review a shortened consent form with a highlights box, where the highlights box includes the 10 sentences rates as most likely to impact a participant's decision from a previous study.
Interactive, shortened consent form
Participants will review an interactive, shortened consent form, where hyperlinks to different sections of the consent form are provided. The landing page includes the introductory section.
Carnegie Mellon University, Pittsburgh
Collaborators (1)
ICON plc
INDUSTRY
Carnegie Mellon University
OTHER